Skip to the stories
Wednesday, 18 November 2026
Saved

Next edition

18:17

Headlines

Medical Science

International trial tests oral bacterial lysate to prevent infant wheeze

Researchers have detailed a multicentre randomised clinical trial protocol to test if oral bacterial lysate reduces recurrent wheezing in infants following severe bronchiolitis.

FTMQ Health, written by our newsroom0 views

Share

Researchers have published a global clinical trial protocol in Pediatric Research to test whether an oral bacterial lysate can prevent recurrent wheezing in infants who were hospitalised for severe bronchiolitis, Bioengineer.org reported. The study is an international multicentre randomised trial designed to evaluate the preventative treatment in vulnerable infants. [1]

Severe bronchiolitis is an acute lower respiratory infection caused primarily by viral pathogens. Bioengineer.org reported that severe bronchiolitis is the most frequent reason infants are hospitalised across high-income countries. Data from clinical registries and cohorts demonstrate that infants who require inpatient care for the condition face a heightened vulnerability to recurrent respiratory complications. [1]

Clinical trials are prospective biomedical or behavioural research studies on human participants designed to evaluate specific interventions, including new treatments and established therapies that require further study. These trials generate data regarding safety, dosage, and efficacy, and they require approval from ethics committees or health authorities before research begins. [4]

Share

In short

  • A clinical trial protocol published in Pediatric Research details an international study on oral bacterial lysate for infants.
  • The trial evaluates whether oral bacterial lysate reduces recurrent wheezing after hospitalisation for severe bronchiolitis.
  • Severe bronchiolitis is the leading cause of infant hospitalisation in high-income countries.

Sources

Every paragraph above points to the numbered items it rests on. Read the originals here.

  1. [1]International Clinical Trial Evaluates Oral Bacterial Lysate for Preventing Infant WheezeBioengineer.org, 5d ago (the report this story comes from)
  2. [2]What Happens After a Clinical Cancer Trial Ends?HealthCentral, 5d ago
  3. [3]Aravax Announces Positive Results of Phase 2 Clinical TrialGlobeNewswire, 5d ago

Background

  1. [4]Clinical trial on Wikipedia
  2. [5]Infant swimming on Wikipedia
  3. [6]Limulus amebocyte lysate on Wikipedia
  4. [7]Severe long COVID linked to altered lung and mouth microbiomes FTMQ Health, 37d ago
  5. [8]Clinical trial begins in Congo to test preventive Ebola drug FTMQ Health, 44d ago

Our newsroom writes these reports with the help of software, from the 8 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.

Earlier reports of ours on the same people and subjects.

More in Medical Science

Get the day in one email

Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments

Loading

Join the conversation

Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.

Already on the list? Enter the same address and we will send a sign-in link.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.